0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research global rheumatic disorders drugs market 2024 increased uptake il inhibitors jak.Your search for "" gave back 1533062 results.
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase SYK...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Interleukin...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2019 Summary Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018 Summary According...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global JAK1 Inhibitor Drug market size is expected to reach $ 16550 million by 2029, rising at a market growth of 7.5% CAGR during the forecast...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global JAK1 Inhibitor Drug market size is projected to grow from US$ 9503.7 million in 2022 to US$ 16380 million in 2029; it is expected to grow...
Catalog:
LPI
July 2023
Price: USD 3,660.00
JAK1 inhibitor drugs are a class of medications that specifically target the Janus kinase 1 (JAK1) enzyme. These drugs work by blocking the activity...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
LPI
February 2023
Price: USD 3,660.00
